Real-time enrollment status for this alzheimer's disease clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 3:51 PM UTC
| NCT Number | NCT06159673 |
| Recruiting Status | Recruiting |
| Condition | Alzheimer's Disease |
| Phase | PHASE2 |
| Target Enrollment | 1,074 participants |
| Active Locations | 45 sites in the US |
| Sponsor | ACADIA Pharmaceuticals Inc. |
| Last Updated on CT.gov | June 16, 2026 (Jun 16, 2026) |
As of July 18, 2026: Clinical trial NCT06159673 is currently recruiting participants. This phase2 study for alzheimer's disease is actively seeking new participants at 45 locations across the United States. The study is sponsored by ACADIA Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06159673 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 45 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06159673 was last updated Jun 16, 2026 (June 16, 2026). HelloStudys verifies this status automatically.